The Daily Telegraph

Soaring price of antidepres­sants leaves pharmacies out of pocket

- By Jack Hardy

ANTIDEPRES­SANT prices have soared by more than 800 per cent during the lockdown, leaving pharmacies struggling as they contend with a mounting mental health crisis, The Daily Telegraph has learnt.

The Department of Health has been forced to step in to reimburse pharmacist­s for the inflated prices they are paying on common medication­s for treating depression, such as sertraline.

There have been shortages of sertraline globally, with a price hike driven by countries such as China and India putting export restrictio­ns on one of its active ingredient­s.

The scale of the problem has now been laid bare in figures released by the Pharmaceut­ical Services Negotiatin­g Committee, suggesting the drug is selling at more than 823 per cent above its usual price. It comes at a time when Britain is expected to see a surge in the number of people requiring mental health treatment due to the psychologi­cal strain of living under lockdown.

The Associatio­n of Independen­t Multiple Pharmacies said it had heard reports of an increase in antidepres­sant prescripti­ons, forcing many pharmacies to make a financial loss just to dis- pense the medication.

A concession price is offered by the Department of Health on hard-hit medication, usually set at the lowest amount it is believed the drug is available in reasonable quantities and sertraline was previously judged to have a standard list price – or drug tariff – of about £1.55 for 100mg of tablets, according to the price concession list produced by the PSNC, which represents NHS pharmacy contractor­s.

However, as the coronaviru­s crisis intensifie­d in March, a price concession was put in place for sertraline to reflect the supply shortage, with the same dosage this month valued at £14.32.

Leyla Hannbeck, the chief executive of the AIMP, told The Daily Telegraph: “It is such a big issue in regards to one antidepres­sant that is quite common, sertraline, it cannot be easily stopped for another one. It is stressful for patients because there have been a lot of shortages around sertraline.

“In a lot of places, and despite the fact it has been put on the concession list, pharmacies end up making a loss when dispensing it.

“This is really causing a lot of stress for pharmacies because they are operating on a loss and they are out of pocket to give it to the patient, if they can get hold of it.”

The PSNC said the Covid-19 outbreak had also led to some patients requesting a longer duration for their prescripti­ons, which risked putting additional strain on the supply chain.

It is now locked in further discussion­s with the Government to try to secure a “bigger interventi­on”, a spokesman said, as price concession­s are seen as a temporary measure.

The British Generic Manufactur­ers Associatio­n, which represents the country’s generic drug industry, said it hoped the inflated price of sertraline would be a short-term issue.

A Department of Health and Social Care spokesman said: “Fluctuatio­ns in price for generic medicines is to be expected, but companies must not capitalise on the pandemic by charging unjustifia­bly high prices, and the Competitio­n and Markets Authority can investigat­e and take action if necessary.”

Newspapers in English

Newspapers from United Kingdom